This test measures the level of Cancer Antigen 125 (CA-125) in the blood. While CA-125 is a tumour marker used primarily to monitor treatment effectiveness in diagnosed ovarian cancer, national guidlines also recommend it for initial investigation in women presenting with certain persistent, non-specific abdominal symptoms.